About the journal
Hematology, Transfusion and Cell Therapy is an open-access journal published by Elsevier in Spain, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 30 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier
- ISSN
- 2531-1379 · 2531-1387
- Country
- Spain
- Languages
- english
- Access
- Open access
- Articles in DOAJ
- 7445
- Declared review time
- 30 weeks
- Declared peer-review model
- double_blind
Index listings
- DOAJ · 2018-05-01
- Indexing
- DOAJ
- APC
- —
- Declared review time (DOAJ)
- 30 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
7445
Most recent article
last month
Average review time (journal-declared via DOAJ)
30weeks
Works in OpenAlex
11020
Last recorded publication year
2026
h-index
30
i10-index
177
From OpenAlex open data (CC0).
Editorial & policy10
- Last DOAJ review date
- 2026-04-27
- Added to DOAJ
- 2018-05-01
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMCPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 8%
- ORCID iDs in current deposits
- 8%
- Deposits licence metadata at Crossref
- ✓
- Peer-review policy
- View policy
Identity & continuity4
- Continues
- 1516-8484, 1806-0870
- Source type
- journal
- NLM unique ID (PubMed)
- 101725732
- Society affiliations
- Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Blood transfusion and management
- Hemoglobinopathies and Related Disorders
- Hemoglobinopathies and Related Disorders
- Lymphoma Diagnosis and Treatment
- Blood donation and transfusion practices
- Blood groups and transfusion
- Acute Myeloid Leukemia Research
- Hemoglobinopathies and Related Disorders
Show all subjects (75)
- Acute Myeloid Leukemia Research
- Acute Myeloid Leukemia Research
- Blood donation and transfusion practices
- Blood donation and transfusion practices
- Hematological disorders and diagnostics
- Acute Lymphoblastic Leukemia research
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Acute Lymphoblastic Leukemia research
- Acute Lymphoblastic Leukemia research
- Chronic Lymphocytic Leukemia Research
- Platelet Disorders and Treatments
- Iron Metabolism and Disorders
- Iron Metabolism and Disorders
- Healthcare during COVID-19 Pandemic
- Healthcare during COVID-19 Pandemic
- Viral-associated cancers and disorders
- Multiple Myeloma Research and Treatments
- Chronic Myeloid Leukemia Treatments
- Chronic Myeloid Leukemia Treatments
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Blood groups and transfusion
- Retinoids in leukemia and cellular processes
- Blood groups and transfusion
- Academic Research in Diverse Fields
- Academic Research in Diverse Fields
- Clinical Laboratory Practices and Quality Control
- Hemophilia Treatment and Research
- Science and Education Research
- Science and Education Research
- Blood transfusion and management
- Blood transfusion and management
- Chronic Myeloid Leukemia Treatments
- Maternal and Neonatal Healthcare
- Maternal and Neonatal Healthcare
- Palliative and Oncologic Care
- Palliative and Oncologic Care
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- COVID-19 Clinical Research Studies
- Women's cancer prevention and management
- Women's cancer prevention and management
- T-cell and Retrovirus Studies
- T-cell and Retrovirus Studies
- Multiple Myeloma Research and Treatments
- Multiple Myeloma Research and Treatments
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Iron Metabolism and Disorders
- Hematopoietic Stem Cell Transplantation
- Hematopoietic Stem Cell Transplantation
- Blood Coagulation and Thrombosis Mechanisms
- Complement system in diseases
- Public Health in Brazil
- Public Health in Brazil
- Neutropenia and Cancer Infections
- Healthcare Regulation
- Healthcare Regulation
- Hemophilia Treatment and Research
- CNS Lymphoma Diagnosis and Treatment
- Hemophilia Treatment and Research
- Rural and Ethnic Education
- Rural and Ethnic Education
- Cutaneous lymphoproliferative disorders research
- Cutaneous lymphoproliferative disorders research
- Organ Donation and Transplantation
Keywords (DOAJ)
- case reports
- hematology
- transfusion
- hemotherapy
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ